Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 931361, 6 pages
http://dx.doi.org/10.1155/2014/931361
Research Article

The (G>A) rs11573191 Polymorphism of PLA2G5 Gene Is Associated with Premature Coronary Artery Disease in the Mexican Mestizo Population: The Genetics of Atherosclerotic Disease Mexican Study

1Departments of Molecular Biology, Endocrinology, and Immunology, National Institute of Cardiology Ignacio Chávez, 14080 Mexico City, DF, Mexico
2Department of Endocrinology, National Institute of Cardiology Ignacio Chávez, Juan Badiano 1, Sección XVI, Tlalpan, 14080 Mexico City, DF, Mexico
3Cardiovascular Genomics Laboratory, National Institute of Genomic Medicine, 14610 Mexico City, DF, Mexico
4Department of Immunology, National Institute of Cardiology Ignacio Chávez, Juan Badiano 1, Sección XVI, Tlalpan, 14080 Mexico City, DF, Mexico
5Laboratory of Genomic Medicine, Research Unit, Juárez de México Hospital, 07760 Mexico City, DF, Mexico

Received 19 February 2014; Revised 2 May 2014; Accepted 4 May 2014; Published 18 May 2014

Academic Editor: Terry K. Smith

Copyright © 2014 Gilberto Vargas-Alarcón et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Ross, “Atherosclerosis—an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. X. García-Moll, “Inflammatory and anti-inflammatory markers in acute coronary syndromes. Ready for use in the clinical setting?” Revista Espanola de Cardiologia, vol. 58, no. 6, pp. 615–617, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. A. J. Lusis, “Atherosclerosis,” Nature, vol. 407, no. 6801, pp. 233–241, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. D. A. Six and E. A. Dennis, “The expanding superfamily of phospholipase A2 enzymes: classification and characterization,” Biochimica et Biophysica Acta, vol. 1488, no. 1-2, pp. 1–19, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Hurt-Camejo, S. Andersen, R. Standal et al., “Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, pp. 300–309, 1997. View at Google Scholar
  6. K. Hanasaki, K. Yamada, S. Yamamoto et al., “Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation,” Journal of Biological Chemistry, vol. 277, no. 32, pp. 29116–29124, 2002. View at Google Scholar · View at Scopus
  7. B. B. Boyanovsky, D. R. Van Der Westhuyzen, and N. R. Webb, “Group V secretory phospholipase A2-modified low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independent process that involves cellular proteoglycans,” Journal of Biological Chemistry, vol. 280, no. 38, pp. 32746–32752, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Ivandic, L. W. Castellani, X.-P. Wang et al., “Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 5, pp. 1284–1290, 1999. View at Google Scholar · View at Scopus
  9. M. A. Bostrom, B. B. Boyanovsky, C. T. Jordan et al., “Group V secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 3, pp. 600–606, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Ait-Oufella, O. Herbin, C. Lahoute et al., “Group X secreted phospholipase A2 limits the development of atherosclerosis in LDL receptor-null mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, pp. 466–473, 2013. View at Google Scholar
  11. H. Sato, R. Kato, Y. Isogai et al., “Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis,” Journal of Biological Chemistry, vol. 283, no. 48, pp. 33483–33497, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Ishimoto, K. Yamada, S. Yamamoto, T. Ono, M. Notoya, and K. Hanasaki, “Group V and X secretory phospholipase A2s-induced modification of high-density lipoprotein linked to the reduction of its antiatherogenic functions,” Biochimica et Biophysica Acta, vol. 1642, no. 3, pp. 129–138, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Rosengren, H. Peilot, M. Umaerus et al., “Secretory phospholipase A2 group V: lesion distribution, activation by arterial proteoglycans, and induction in aorta by a western diet,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 7, pp. 1579–1585, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. J. A. Tischfield, Y. R. Xia, D. M. Shih et al., “Low-molecular weight, calciumdependent phospholipase A2 genes are linked and map to homologous chromosome regions in mouse and human,” Genomics, vol. 32, pp. 328–333, 1996. View at Google Scholar
  15. P. T. E. Wootton, N. L. Arora, F. Drenos et al., “Tagging SNP haplotype analysis of the secretory PLA2-V gene, PLA2G5, shows strong association with LDL and oxLDL levels, suggesting functional distinction from sPLA2-IIA: results from the UDACS study,” Human Molecular Genetics, vol. 16, no. 12, pp. 1437–1444, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Villarreal-Molina, C. Posadas-Romero, S. Romero-Hidalgo et al., “The ABCA1 gene R230C variant is associated with decreased risk of premature coronary artery disease: the genetics of atherosclerotic disease (GEA) study,” PLoS ONE, vol. 7, Article ID e49285, 2012. View at Google Scholar
  17. E. Valentin, A. G. Singer, F. Ghomashchi, M. Lazdunski, M. H. Gelb, and G. Lambeau, “Cloning and recombinant expression of human group IIF-secreted phospholipase A2,” Biochemical and Biophysical Research Communications, vol. 279, no. 1, pp. 223–228, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Kolko, N. R. Christoffersen, S. G. Barreiro, and N. G. Bazan, “Expression and location of mRNAs encoding multiple forms of secretory phospholipase A2 in the rat retina,” Journal of Neuroscience Research, vol. 77, no. 4, pp. 517–524, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Cupillard, K. Koumanov, M. G. Mattéi, M. Lazdunski, and G. Lambeau, “Cloning, chromosomal mapping, and expression of a novel human secretory phospholipase A2,” The Journal of Biological Chemistry, vol. 272, pp. 15745–15752, 1997. View at Google Scholar
  20. M. C. Seeds, K. A. Jones, R. D. Hite et al., “Cell-specific expression of Group X and Group V secretory phospholipases A2 in human lung airway epithelial cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 23, no. 1, pp. 37–44, 2000. View at Google Scholar · View at Scopus
  21. N. Suzuki, J. Ishizaki, Y. Yokota et al., “Structures, enzymatic properties, and expression of novel human and mouse secretory phospholipase A2s,” Journal of Biological Chemistry, vol. 275, no. 8, pp. 5785–5793, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Masuda, M. Murakami, Y. Ishikawa, T. Ishii, and I. Kudo, “Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues,” Biochimica et Biophysica Acta, vol. 1736, no. 3, pp. 200–210, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Masuda, M. Murakami, M. Mitsuishi et al., “Expression of secretory phospholipase A2 enzymes in lungs of humans with pneumonia and their potential prostaglandin-synthetic function in human lung-derived cells,” Biochemical Journal, vol. 387, no. 1, pp. 27–38, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. K. P. Kim, J. D. Rafter, L. Bittova et al., “Mechanism of human group V phospholipase A2 (PLA2)-induced leukotriene biosynthesis in human neutrophils: a potential role of heparan sulfate binding in PLA2 internalization and degradation,” Journal of Biological Chemistry, vol. 276, no. 14, pp. 11126–11134, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Balestrieri and J. P. Arm, “Group V sPLA2: classical and novel functions,” Biochimica et Biophysica Acta, vol. 1761, no. 11, pp. 1280–1288, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Murakami, S. Masuda, S. Shimbara, Y. Ishikawa, T. Ishii, and I. Kudo, “Cellular distribution, post-translational modification, and tumorigenic potential of human group III secreted phospholipase A2,” Journal of Biological Chemistry, vol. 280, no. 26, pp. 24987–24998, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Ohta, M. Imamura, W. Xing, J. A. Boyce, and B. Balestrieri, “Group V secretory phospholipase A2 is involved in macrophage activation and is sufficient for macrophage effector functions in allergic pulmonary inflammation,” The Journal of Immunology, vol. 190, pp. 5927–5938, 2013. View at Google Scholar
  28. N. M. Muñoz, A. Y. Meliton, J. P. Arm, J. V. Bonventre, W. Cho, and A. R. Leff, “Deletion of secretory group V phospholipase A2 attenuates cell migration and airway hyperresponsiveness in immunosensitized mice,” Journal of Immunology, vol. 179, no. 7, pp. 4800–4807, 2007. View at Google Scholar · View at Scopus
  29. G. Giannattasio, D. Fujioka, W. Xing, H. R. Katz, J. A. Boyce, and B. Balestrieri, “Group v secretory phospholipase A2 reveals its role in house dust mite-induced allergic pulmonary inflammation by regulation of dendritic cell function,” Journal of Immunology, vol. 185, no. 7, pp. 4430–4438, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Boyanovsky, M. Zack, K. Forrest, and N. R. Webb, “The capacity of group V sPLA2 to increase atherogenicity of ApoE-/- and LDLR-/- mouse LDL in vitro predicts its atherogenic role in vivo,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 4, pp. 532–538, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. S. J. Nicholls, J. J. Kastelein, G. G. Schwartz et al., “Varespladib and cardiovascular events in patients with acute coronary syndrome: the VISTA-16 randomized clinical trial,” JAMA, vol. 311, pp. 252–262, 2014. View at Google Scholar
  32. P. T. E. Wootton, F. Drenos, J. A. Cooper et al., “Tagging-SNP haplotype analysis of the secretory PLA2IIa gene PLA2G2A shows strong association with serum levels of sPLA2IIa: results from the UDACS study,” Human Molecular Genetics, vol. 15, no. 2, pp. 355–361, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. M. V. Holmes, H. J. Exeter, L. Folkersen et al., “Novel genetic approach to investigate the role of plasma secretory phospholipase A2 (sPLA2)-V isoenzyme in coronary herat disease,” Circulation: Cardiovascular Genetics, vol. 7, pp. 144–150, 2014. View at Google Scholar
  34. M. Mancini, E. Petretto, C. Kleinert et al., “Mapping genetic determinants of coronary microvascular remodeling in the spontaneously hypertensive rat,” Basic Research in Cardiology, vol. 108, p. 316, 2013. View at Google Scholar